Copyright Reports & Markets. All rights reserved.

Global Neuroprotective Products Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Neuroprotective Products Market Overview

      • 1.1 Product Overview and Scope of Neuroprotective Products
      • 1.2 Neuroprotective Products Segment by Type
        • 1.2.1 Global Neuroprotective Products Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Cholinesterase inhibitors
        • 1.2.3 NMDA receptor antagonists
        • 1.2.4 Others
      • 1.3 Neuroprotective Products Segment by Application
        • 1.3.1 Neuroprotective Products Consumption Comparison by Application (2014-2025)
        • 1.3.2 Alzheimer's disease
        • 1.3.3 Multiple sclerosis
        • 1.3.4 Others
      • 1.4 Global Neuroprotective Products Market by Region
        • 1.4.1 Global Neuroprotective Products Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Neuroprotective Products Market Size
        • 1.5.1 Global Neuroprotective Products Revenue (2014-2025)
        • 1.5.2 Global Neuroprotective Products Production (2014-2025)

      2 Global Neuroprotective Products Market Competition by Manufacturers

      • 2.1 Global Neuroprotective Products Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Neuroprotective Products Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Neuroprotective Products Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Neuroprotective Products Production Sites, Area Served, Product Types
      • 2.5 Neuroprotective Products Market Competitive Situation and Trends
        • 2.5.1 Neuroprotective Products Market Concentration Rate
        • 2.5.2 Neuroprotective Products Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Neuroprotective Products Production Market Share by Regions

      • 3.1 Global Neuroprotective Products Production Market Share by Regions
      • 3.2 Global Neuroprotective Products Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Neuroprotective Products Production
        • 3.4.1 North America Neuroprotective Products Production Growth Rate (2014-2019)
        • 3.4.2 North America Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Neuroprotective Products Production
        • 3.5.1 Europe Neuroprotective Products Production Growth Rate (2014-2019)
        • 3.5.2 Europe Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Neuroprotective Products Production (2014-2019)
        • 3.6.1 China Neuroprotective Products Production Growth Rate (2014-2019)
        • 3.6.2 China Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Neuroprotective Products Production (2014-2019)
        • 3.7.1 Japan Neuroprotective Products Production Growth Rate (2014-2019)
        • 3.7.2 Japan Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Neuroprotective Products Consumption by Regions

      • 4.1 Global Neuroprotective Products Consumption by Regions
      • 4.2 North America Neuroprotective Products Consumption (2014-2019)
      • 4.3 Europe Neuroprotective Products Consumption (2014-2019)
      • 4.4 China Neuroprotective Products Consumption (2014-2019)
      • 4.5 Japan Neuroprotective Products Consumption (2014-2019)

      5 Global Neuroprotective Products Production, Revenue, Price Trend by Type

      • 5.1 Global Neuroprotective Products Production Market Share by Type (2014-2019)
      • 5.2 Global Neuroprotective Products Revenue Market Share by Type (2014-2019)
      • 5.3 Global Neuroprotective Products Price by Type (2014-2019)
      • 5.4 Global Neuroprotective Products Production Growth by Type (2014-2019)

      6 Global Neuroprotective Products Market Analysis by Applications

      • 6.1 Global Neuroprotective Products Consumption Market Share by Application (2014-2019)
      • 6.2 Global Neuroprotective Products Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Neuroprotective Products Business

      • 7.1 Genervon Biopharmaceuticals (Canada)
        • 7.1.1 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Production Sites and Area Served
        • 7.1.2 Neuroprotective Products Product Introduction, Application and Specification
        • 7.1.3 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 NeuroVive Pharmaceutical (Sweden)
        • 7.2.1 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Production Sites and Area Served
        • 7.2.2 Neuroprotective Products Product Introduction, Application and Specification
        • 7.2.3 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Ceregene (USA)
        • 7.3.1 Ceregene (USA) Neuroprotective Products Production Sites and Area Served
        • 7.3.2 Neuroprotective Products Product Introduction, Application and Specification
        • 7.3.3 Ceregene (USA) Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 BHRPharma (Thailand)
        • 7.4.1 BHRPharma (Thailand) Neuroprotective Products Production Sites and Area Served
        • 7.4.2 Neuroprotective Products Product Introduction, Application and Specification
        • 7.4.3 BHRPharma (Thailand) Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Neuren Pharmaceuticals (Australia)
        • 7.5.1 Neuren Pharmaceuticals (Australia) Neuroprotective Products Production Sites and Area Served
        • 7.5.2 Neuroprotective Products Product Introduction, Application and Specification
        • 7.5.3 Neuren Pharmaceuticals (Australia) Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Allon therapeutics (Canada)
        • 7.6.1 Allon therapeutics (Canada) Neuroprotective Products Production Sites and Area Served
        • 7.6.2 Neuroprotective Products Product Introduction, Application and Specification
        • 7.6.3 Allon therapeutics (Canada) Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Bionure Inc. (USA)
        • 7.7.1 Bionure Inc. (USA) Neuroprotective Products Production Sites and Area Served
        • 7.7.2 Neuroprotective Products Product Introduction, Application and Specification
        • 7.7.3 Bionure Inc. (USA) Neuroprotective Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served

      8 Neuroprotective Products Manufacturing Cost Analysis

      • 8.1 Neuroprotective Products Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Neuroprotective Products
      • 8.4 Neuroprotective Products Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Neuroprotective Products Distributors List
      • 9.3 Neuroprotective Products Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Neuroprotective Products Market Forecast

      • 11.1 Global Neuroprotective Products Production, Revenue Forecast
        • 11.1.1 Global Neuroprotective Products Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Neuroprotective Products Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Neuroprotective Products Price and Trend Forecast (2019-2025)
      • 11.2 Global Neuroprotective Products Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Neuroprotective Products Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Neuroprotective Products Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Neuroprotective Products Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Neuroprotective Products Production, Revenue Forecast (2019-2025)
      • 11.3 Global Neuroprotective Products Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Neuroprotective Products Consumption Forecast (2019-2025)
        • 11.3.2 Europe Neuroprotective Products Consumption Forecast (2019-2025)
        • 11.3.3 China Neuroprotective Products Consumption Forecast (2019-2025)
        • 11.3.4 Japan Neuroprotective Products Consumption Forecast (2019-2025)
      • 11.4 Global Neuroprotective Products Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Neuroprotective Products Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Neuroprotective Products consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions. 

        The global Neuroprotective Products market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Neuroprotective Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuroprotective Products market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Genervon Biopharmaceuticals (Canada)
        NeuroVive Pharmaceutical (Sweden)
        Ceregene (USA)
        BHRPharma (Thailand)
        Neuren Pharmaceuticals (Australia)
        Allon therapeutics (Canada)
        Bionure Inc. (USA)
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Cholinesterase inhibitors
        NMDA receptor antagonists
        Others

        Segment by Application
        Alzheimer's disease
        Multiple sclerosis
        Others

        Buy now